Polyphenolics will present exciting news about grape seed extract’s emerging role in managing health issues.
Cardiovascular disease and diabetes continue to take their toll on our healthcare system. Polyphenolics will present exciting news about grape seed extract’s emerging role in managing these health issues during this year’s SupplySide West. During this presentation, Beyond Antioxidants: A New Generation of Grape Seed Polyphenol Extracts, attendees will discover how leading physicians are incorporating this non-drug product into patients’ healthcare regimens. This expert panel will also discuss breakthrough University of California–Davis research, labeling language for product formulations, and how these ingredients may help expand heart-health and pre-diabetic product lines. The presentation will take place Wednesday, November 7, from 8:00 A.M. to 8:50 A.M. in the Education Room, Casanova 503 and 504. A four-member expert panel reveals breakthrough UC Davis research
Booth #18079
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.